Machine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.
Page 6 of 7
Mar 11, 2026In an ambitious move to transform the scientific landscape, Radial aims to dismantle traditional barriers in research methodologies by leveraging AI technologies. Backed by substantial funding, this initiative seeks to usher in an era of accelerated discovery and enhanced reproducibility in science.
Mar 7, 2026The partnership marks a significant step in integrating agentic AI models into healthcare operations, promising improvements in efficiency, patient care, and financial processes across key industry players.
Mar 6, 2026A new trend is emerging in healthcare artificial intelligence startups that ties their pricing to the real-world value they deliver, such as completed clinical tasks or patient outcome improvements. Despite investor enthusiasm for this outcome-driven approach, hospital systems largely favor predictable, fixed pricing models. This post analyzes the dynamics of these innovative pricing strategies, hospital reactions, and implications for the future of AI adoption in healthcare.
Feb 27, 2026The evolving healthcare ecosystem in 2026 is underscored by the increasing adoption of artificial intelligence to streamline administrative processes and strategic partnerships that boost therapeutic pipelines. This article analyzes recent developments and assesses their broader impact on the industry’s innovation trajectory and operational excellence.
Feb 27, 2026Elevance Health is strategically integrating artificial intelligence into its healthcare operations. This approach aims to streamline key processes such as insurance approvals and claims handling. However, the company remains cautious by keeping denial decisions under human review to balance efficiency with accuracy.
Feb 25, 2026This collaboration between Mayo Clinic and Merck represents a critical advancement in applying artificial intelligence to healthcare data, with an ambitious goal to improve the accuracy and utility of prognostic models. Leveraging patient data for AI training promises to facilitate earlier diagnosis and personalized treatment interventions across a spectrum of diseases.
Feb 14, 2026The infusion of $40 million funding into Anterior marks a significant advancement in leveraging artificial intelligence to transform administrative processes in healthcare. By enabling near-instantaneous care approvals, this technology promises to alleviate clinician burdens and optimize payer operations.
Feb 11, 2026While AI has been heralded for its potential in accelerating drug discovery, its immediate financial impact on major pharma firms is primarily driven by operational efficiencies and other innovative applications. Companies like Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb, and AstraZeneca exemplify this broader utilization of AI, reshaping the business of pharma.
Feb 4, 2026Epic's AI Charting technology leverages advanced AI methodologies to automate and enhance electronic health record documentation. This development could alter the landscape of ambient scribe services and redefine clinician workflows.
Feb 4, 2026As artificial intelligence technology continues to permeate healthcare, Alaffia Health is positioning itself to address the increasing need for efficiency among payers. By leveraging clinically informed AI to streamline administrative operations and reduce waste within healthcare claims, the company recently secured $55 million in investment to accelerate its platform's development and adoption. This funding milestone highlights the growing recognition of AI's role beyond providers and into payer organizations that face pressures to modernize systems and improve operational outcomes.
Jan 23, 2026The healthcare AI sector is poised for significant expansion in 2026, with transformative impacts expected across clinical applications, value-based care models, and data infrastructure. Bessemer’s insights underscore a surge in AI-driven innovation that could reshape patient care and health system efficiencies.
Jan 22, 2026Menopause and perimenopause have historically been areas of healthcare with limited personalized treatment options. The NIH-backed Amissa startup aims to change that narrative by leveraging artificial intelligence to aggregate and analyze data, providing improved care strategies for women undergoing these life stages. This detailed exploration delves into the technology behind Amissa's platform and its potential impact on women's health.
Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.
Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.
Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.
Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.
FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.